Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.170NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.170NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.170NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.506NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.506NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.506NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.6.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.6.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.6.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.438.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.438.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.438.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.27NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.27NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.188NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.188NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.188NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.39NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-19353.7US
B.1.39NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.39NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.357NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.357NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.357NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BP.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BP.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.46NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.46NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.46NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.530NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.530NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.530NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.17.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.17.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-903.077Singapore
BA.1.17.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.75.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used